Gerber Hans-Peter 4
4 · SUTRO BIOPHARMA, INC. · Filed Sep 22, 2025
Insider Transaction Report
Form 4
Gerber Hans-Peter
CHIEF SCIENTIFIC OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units (RSUs)
2025-09-18−37,500→ 75,000 totalExp: 2027-09-18→ Common Stock (37,500 underlying) - Exercise/Conversion
Common Stock
2025-09-18+37,500→ 68,249 total - Tax Payment
Common Stock
2025-09-18$0.90/sh−13,417$12,075→ 54,832 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSU award vests annually as to 1/4th of the total award beginning on September 18, 2024, subject to the reporting person's continued service to the Issuer on each vesting date.